Companion Animal Vaccines Market Volume Analysis, Segments, Value Share and Key Trends 2016-2026
Companion animal vaccines are used to stimulate an immune response in pets such as canine, avian and feline. These vaccine products are of various types such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated live vaccines are derived from disease-causing pathogens such as virus or bacteria, which have been weakend under laboratory conditions. Conjugate vaccines are an antigen or toxoid-containing preparation that is linked to polysaccharides and stimulate the immature immune system to defend against the disease-causing organism. Inactivated vaccines are made from microorganisms such as viruses and bacteria that have been killed through physical or chemical processes. Subunit vaccines, like inactivated whole-cell vaccines, do not contain live components of the pathogen. Toxoid vaccines are based on the toxin produced by certain bacteria, which is rendered harmless and used as the antigen in the vaccine to elicit an immune response. DNA vaccines are manufactured by inserting DNA into a bacterial plasmid, which functions as the vector. Recombinant vaccines are produced by genetic engineering technology and use attenuated virus or bacterium as a vector to introduce microbial DNA to the cells of the body. The global companion animal vaccines market was valued at more than US$ 2,100 Mn in 2015 and is projected to register a CAGR of 6.8% during the forecast period. The market is expected to be valued at nearly US$ 4,500 Mn by the end of 2026. Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1427
Companion animal vaccines are used to stimulate an immune response in pets such as canine, avian and feline. These vaccine products are of various types such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated live vaccines are derived from disease-causing pathogens such as virus or bacteria, which have been weakend under laboratory conditions. Conjugate vaccines are an antigen or toxoid-containing preparation that is linked to polysaccharides and stimulate the immature immune system to defend against the disease-causing organism. Inactivated vaccines are made from microorganisms such as viruses and bacteria that have been killed through physical or chemical processes. Subunit vaccines, like inactivated whole-cell vaccines, do not contain live components of the pathogen. Toxoid vaccines are based on the toxin produced by certain bacteria, which is rendered harmless and used as the antigen in the vaccine to elicit an immune response. DNA vaccines are manufactured by inserting DNA into a bacterial plasmid, which functions as the vector. Recombinant vaccines are produced by genetic engineering technology and use attenuated virus or bacterium as a vector to introduce microbial DNA to the cells of the body.
The global companion animal vaccines market was valued at more than US$ 2,100 Mn in 2015 and is projected to register a CAGR of 6.8% during the forecast period. The market is expected to be valued at nearly US$ 4,500 Mn by the end of 2026.
Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1427
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Companion</strong> <strong>Animal</strong> <strong>Vaccines</strong> <strong>Market</strong>: Global Industry<br />
<strong>Analysis</strong> <strong>and</strong> Opportunity Assessment, <strong>2016</strong>–<strong>2026</strong><br />
April 2017<br />
Report Id : REP-GB-1427<br />
Status : Apr -2017<br />
Category : Healthcare, Pharmaceuticals & Medical Devices<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved
About<br />
Future <strong>Market</strong> Insights<br />
Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, custom<br />
research reports, <strong>and</strong> consulting services. We deliver a complete packaged solution, which<br />
combines current market intelligence, statistical anecdotes, technology inputs, valuable growth<br />
insights, aerial view of the competitive framework, <strong>and</strong> future market trends.<br />
We provide research services at a global as well as regional level; key regions include GCC,<br />
ASEAN, <strong>and</strong> BRIC.<br />
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy,<br />
Technology, Healthcare, <strong>and</strong> Retail.<br />
We have a global presence with delivery centers across India specializing in providing global<br />
research reports <strong>and</strong> country research reports. FMI is headquartered out of London, U.K., with a<br />
state-of-the-art delivery center located in Pune, India. We combine our knowledge <strong>and</strong> learning<br />
from every corner of the world to distill it to one thing – the perfect solution for our client.<br />
Research Capabilities<br />
Sector Coverage<br />
<br />
<br />
<br />
<br />
Customized Research<br />
Syndicated Research<br />
Investment Research<br />
Social Media Research<br />
<br />
<br />
<br />
<br />
Automotive <strong>and</strong> Transportation<br />
Electronics, Semiconductor, <strong>and</strong> ICT<br />
Retail <strong>and</strong> Consumer Products<br />
Industrial Automation <strong>and</strong> Equipment<br />
<br />
<br />
<br />
<br />
Chemicals & Materials<br />
Food <strong>and</strong> Beverages<br />
Services <strong>and</strong> Utilities<br />
Energy, Mining, Oil, <strong>and</strong> Gas<br />
Customized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Subscription Information<br />
For detailed subscription information please contact<br />
Hari. T (Sr. Manager - Global Business Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
2
Research Methodology (1/2)<br />
Systematic Research Approach<br />
<strong>Market</strong> profiling<br />
Formulating discussion guide<br />
Developing list of respondents<br />
Data collection<br />
Data validation<br />
4<br />
5<br />
3<br />
1<br />
2<br />
In-depth secondary research is used to<br />
ascertain overall market size, top<br />
industry players, top products, industry<br />
associations, etc.<br />
PMR formulates a detailed discussion<br />
guide to conduct expert <strong>and</strong> industry<br />
interviews<br />
PMR develops a list of industry players<br />
(manufacturers), distributors, retailers<br />
<strong>and</strong> industry experts<br />
PMR conducts interviews with industry<br />
experts, industry players, distributors<br />
<strong>and</strong> retailers<br />
Data is validated by triangulation<br />
method, wherein secondary, primary<br />
<strong>and</strong> PMR analysis contribute to the final<br />
data<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Data<br />
Collection<br />
Data Filter<br />
& <strong>Analysis</strong><br />
Identifying key opinion leaders<br />
Questionnaire design<br />
In-depth interviews<br />
Coverage across value chain<br />
<strong>Market</strong> participants<br />
<strong>Key</strong> strengths<br />
Product portfolio<br />
Mapping as per value chain<br />
<strong>Key</strong> focus segments<br />
A<br />
Primary<br />
Research<br />
C<br />
Company<br />
<strong>Analysis</strong><br />
Research &<br />
Intelligence<br />
SOLUTION<br />
Actionable<br />
Insights<br />
B<br />
Desk<br />
Research<br />
<br />
<br />
<br />
<br />
<br />
<br />
Business<br />
Solution<br />
<strong>Key</strong> industry experts<br />
Channel study<br />
Developments<br />
<strong>Market</strong> dynamics<br />
Products<br />
Conclusions<br />
Data analysis<br />
6<br />
Data is scrutinized using MS-Excel to<br />
obtain qualitative <strong>and</strong> quantitative<br />
insights about the industry<br />
Primary Research #<br />
Secondary Research #<br />
Paid Publications#<br />
Insights<br />
7<br />
PMR delivers industry insights <strong>and</strong><br />
information in the required format<br />
(PDF)<br />
<br />
<br />
<br />
<br />
Linkedin<br />
Zoominfo<br />
Salesforce<br />
Avention<br />
<br />
<br />
<br />
<br />
Company websites<br />
Company annual<br />
reports<br />
White papers<br />
Financial reports<br />
<br />
<br />
<br />
<br />
Factiva<br />
GBI<br />
Genios<br />
Meltwater<br />
# includes sources of databases<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
3
<strong>Companion</strong> <strong>Animal</strong> <strong>Vaccines</strong> <strong>Market</strong><br />
Zoetis <strong>and</strong> Merck Dominate US$ 2.26 Bn <strong>Companion</strong> <strong>Animal</strong> <strong>Vaccines</strong> <strong>Market</strong><br />
Zoetis Inc. will continue to account for a leading share of the US$ 2.26 Bn (<strong>2016</strong>) global companion<br />
animal vaccine market. The pharmaceutical company accounted for over 46% share of the global market<br />
in 2015, <strong>and</strong> it is expected to maintain its numero uno position during the forecast period <strong>2016</strong>-<strong>2026</strong>.<br />
Merck & Co., Inc. <strong>and</strong> Merial, will remain the other key players in this market.<br />
The key factors that will fuel dem<strong>and</strong> for companion animal vaccines include,<br />
Increasing trend of pet humanisation in developing countries<br />
Adoption of pet vaccination programmes, such as ‘herd immunity’ <strong>and</strong> ‘One Health’<br />
Increasing emphasis on preventing <strong>and</strong> detecting avian flu<br />
Rising pet insurance rates in the U.S. <strong>and</strong> other developed countries<br />
Awareness on the benefits of preventive healthcare over reactive healthcare<br />
Collaboration among leading pharmaceutical manufacturers for research <strong>and</strong> development.<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 4
<strong>Companion</strong> <strong>Animal</strong> <strong>Vaccines</strong> <strong>Market</strong><br />
According to Future <strong>Market</strong> Insights’ research, lack of information on emerging virulent veterinary<br />
diseases, <strong>and</strong> decline sales revenues through veterinarians can stifle dem<strong>and</strong> for companion animal<br />
vaccines during the forecast period. The longst<strong>and</strong>ing challenges with correctly identifying <strong>and</strong><br />
underst<strong>and</strong>ing antigen/immunogenic structures can also negatively impact the growth of the market.<br />
Nearly US$ 764 Mn worth of attenuated live vaccines were sold globally in <strong>2016</strong>. This segment is<br />
projected to grow at a CAGR of 7.3% during the forecast period <strong>2016</strong>-<strong>2026</strong>.<br />
Distribution Channel <strong>Analysis</strong>: Veterinary Clinics will Remain the Preferred Distribution Channel<br />
Veterinary clinics continue to be the preferred distribution channel for pharma companies, followed by<br />
veterinary hospitals. These two point of care centres witness substantial footfall of pet owners all year<br />
round, <strong>and</strong> drug companies continuously focus on increasing sales through these channels. In <strong>2016</strong>, these<br />
two distribution channels collectively accounted for nearly 75% revenue share of the market. By the end<br />
of forecast period, the status quo is expected to remain unchanged. Retail pharmacies, which held 20%<br />
share of the market in <strong>2016</strong>, will grow at the highest CAGR during the forecast period.<br />
North America - Largest <strong>Market</strong> for <strong>Companion</strong> <strong>Animal</strong> <strong>Vaccines</strong><br />
The U.S. continues to be a leading market for companion animal vaccines. High level of awareness among<br />
pet owners, combined with easy availability of pet healthcare have resulted into the growth of the<br />
market in the U.S. On account of strong dem<strong>and</strong> in the U.S., North America will continue to be the largest<br />
market globally.<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 5
<strong>Companion</strong> <strong>Animal</strong> <strong>Vaccines</strong> <strong>Market</strong><br />
The North America companion animals market was valued at nearly US$ 676 in <strong>2016</strong>. It is projected to<br />
increase at 6.9% CAGR through <strong>2026</strong>, reaching over US$ 1.3 Bn in revenues. Western Europe, the secondlargest<br />
market for companion animal vaccines is projected to grow at 7.1% CAGR through <strong>2026</strong>.<br />
Overall, Future <strong>Market</strong> Insights maintains a positive outlook on the global companion animal vaccines<br />
market, projecting it to grow at 6.8% CAGR during the forecast period <strong>2016</strong>-<strong>2026</strong>.<br />
Click here to<br />
Order a free sample<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 6
Table of Content<br />
1. Executive Summary<br />
2. <strong>Market</strong> Introduction<br />
2.1. <strong>Companion</strong> <strong>Animal</strong> <strong>Vaccines</strong> <strong>Market</strong> Definition<br />
2.2. <strong>Companion</strong> <strong>Animal</strong> <strong>Vaccines</strong> <strong>Market</strong> Taxonomy<br />
2.3. Veterinary <strong>Vaccines</strong> <strong>Market</strong><br />
3. <strong>Companion</strong> <strong>Animal</strong> <strong>Vaccines</strong> <strong>Market</strong> <strong>Analysis</strong> Scenario<br />
3.1. Regulations <strong>and</strong> Reimbursement Scenario<br />
3.2. Global Company <strong>Market</strong> <strong>Share</strong> <strong>Analysis</strong> (2015)<br />
3.3. Mechanism for Veterinary Product Approval<br />
3.4. <strong>Companion</strong> <strong>Animal</strong> <strong>Vaccines</strong> <strong>Market</strong> Overview<br />
3.4.1. List of Active Participants<br />
4. <strong>Companion</strong> <strong>Animal</strong> <strong>Vaccines</strong> <strong>Market</strong> Dynamics<br />
4.1. Macro-economic Factors<br />
4.2. Drivers<br />
4.2.1. Supply Side<br />
4.2.2. Dem<strong>and</strong> Side<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
7
Table of Content<br />
4.3. Restraints<br />
4.4. Opportunity<br />
4.5. Global <strong>Trends</strong><br />
5. Global <strong>Companion</strong> <strong>Animal</strong> <strong>Vaccines</strong> <strong>Market</strong> <strong>Analysis</strong> <strong>and</strong> Forecast, By Product Type<br />
5.1. Introduction<br />
5.1.1. Basis Point <strong>Share</strong> (BPS) <strong>Analysis</strong> By Product Type<br />
5.1.2. Y-o-Y Growth Projections By Product Type<br />
5.2. <strong>Market</strong> Size (US$ Mn) Forecast By Product Type<br />
5.2.1. Attenuated Live <strong>Vaccines</strong><br />
5.2.2. Conjugate <strong>Vaccines</strong><br />
5.2.3. Inactivated <strong>Vaccines</strong><br />
5.2.4. Subunit <strong>Vaccines</strong><br />
5.2.5. Toxoid <strong>Vaccines</strong><br />
5.2.6. DNA <strong>Vaccines</strong><br />
5.2.7. Recombinant <strong>Vaccines</strong><br />
5.3. <strong>Market</strong> Attractiveness <strong>Analysis</strong> By Product Type<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
8
Table of Content<br />
6. Global <strong>Companion</strong> <strong>Animal</strong> <strong>Vaccines</strong> <strong>Market</strong> <strong>Analysis</strong> <strong>and</strong> Forecast, By Distribution Channel<br />
6.1. Introduction<br />
6.1.1. Basis Point <strong>Share</strong> (BPS) <strong>Analysis</strong> By Distribution Channel<br />
6.1.2. Y-o-Y Growth Projections By Distribution Channel<br />
6.1.3. Comparative <strong>Analysis</strong> By Distribution Channel<br />
6.2. <strong>Market</strong> Size (US$ Mn) Forecast By Distribution Channel<br />
6.2.1. Veterinary Clinics<br />
6.2.2. Veterinary Hospitals<br />
6.2.3. Veterinary Research Institutes<br />
6.2.4. Retail Pharmacies & Others<br />
6.3. <strong>Market</strong> Attractiveness <strong>Analysis</strong> By Distribution Channel<br />
6.4. Prominent <strong>Trends</strong><br />
7. Global <strong>Companion</strong> <strong>Animal</strong> <strong>Vaccines</strong> <strong>Market</strong> <strong>Analysis</strong> <strong>and</strong> Forecast, By Species Type<br />
7.1. Introduction<br />
7.1.1. Basis Point <strong>Share</strong> (BPS) <strong>Analysis</strong> By Species Type<br />
7.1.2. Y-o-Y Growth Projections By Species Type<br />
7.1.3. Comparative <strong>Analysis</strong> By Species Type<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
9
Table of Content<br />
7.2. <strong>Market</strong> Size (US$ Mn) Forecast By Species Type<br />
7.2.1. Canine<br />
7.2.2. Avian<br />
7.2.3. Feline<br />
7.3. <strong>Market</strong> Attractiveness <strong>Analysis</strong> By Species Type<br />
8. Global <strong>Companion</strong> <strong>Animal</strong> <strong>Vaccines</strong> <strong>Market</strong> <strong>Analysis</strong> <strong>and</strong> Forecast, By Region<br />
8.1. Introduction<br />
8.1.1. Basis Point <strong>Share</strong> (BPS) <strong>Analysis</strong> By Region<br />
8.1.2. Y-o-Y Growth Projections By Region<br />
Click here to<br />
Order a free sample<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
10
To know more about us, please visit our website:<br />
www.futuremarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarketinsights.com<br />
For media queries, contact the press office at<br />
press@futuremarketinsights.com<br />
For other queries contact:<br />
Hari. T (Sr. Manager - Global Business Development)<br />
Future <strong>Market</strong> Insights: 3rd Floor,<br />
207 Regent Street, London W1B 3HH<br />
T: +44 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com<br />
Thank You<br />
Future <strong>Market</strong> Insights Global & Consulting Private Limited (FMI)<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
11
Change language